Literature DB >> 8699028

Assessment of in vivo attachment/phagocytosis by alveolar macrophages.

T Weaver1, C L Hall, D L Kachel, R P Ward, M D Williams, D G Perry, P Wisniowski, W J Martin.   

Abstract

Alveolar macrophages (AMs) are recognized as an important first line of cellular host defense within the lung. Although mechanisms underlying AM response to microorganisms or particulates are well characterized in vitro, experimental approaches to the study of AMs in vivo are limited. To circumvent these limitations, a new assay was developed using fluorescently labelled liposomes or Pneumocystis carinii (PC) organisms which were administered intratracheally into mechanically ventilated rats. After 30 min, the lungs were lavaged and the percentage of administered liposomes or PC bound to AMs was determined by quantifying fluorescence. Factors known to enhance attachment/phagocytosis by AMs in vitro were assayed to determine their effect in vivo. For example, vitronectin (VN)-coated liposomes increased attachment from 25.2 +/- 2.4% to 47.2 +/- 3.0% (p < 0.001), while addition of VN increased the binding of PC to AMs from 16.5 +/- 1.7% to 24.5 +/- 2.2% (p < 0.05). Confocal laser microscopy of cells obtained by lavage provided morphologic evidence of attachment/phagocytosis by AMs. This model will permit the quantitative assessment of the interaction of fluorescently labelled liposomes or microorganisms with AMs in the lower respiratory tract of living animals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699028     DOI: 10.1016/0022-1759(96)00031-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  A novel approach to restore lung immunity during systemic immunosuppression.

Authors:  William J Martin; Min Wu; Rajamouli Pasula
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

2.  Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine.

Authors:  W T Jansen; M Väkeväinen-Anttila; H Käyhty; M Nahm; N Bakker; J Verhoef; H Snippe; A F Verheul
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

3.  Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice.

Authors:  M Wu; S Hussain; Y H He; R Pasula; P A Smith; W J Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

4.  Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.

Authors:  Jing Wang; Francis Gigliotti; Samir P Bhagwat; Thaddeus C George; Terry W Wright
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

5.  Airway delivery of interferon-γ overexpressing macrophages confers resistance to Mycobacterium avium infection in SCID mice.

Authors:  Rajamouli Pasula; Bradley E Britigan; Banurekha Kesavalu; Maher Y Abdalla; William J Martin
Journal:  Physiol Rep       Date:  2016-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.